Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by TheCypheron Sep 26, 2018 11:31pm
260 Views
Post# 28698317

Hamish Sutherland - CSO OF PREV and advisor to CannTab

Hamish Sutherland - CSO OF PREV and advisor to CannTabPossible crossover between PreveCeuticals ($PREV) and ($PILL) and ($HUGE).

PreveCeuticals has a proprietary medical grade extraction protocol, applicable to CBD/THC, they also own the rights to an FDA approved spray gel application agent known as Sol-Gel. They’re currently completing trials with raw material provided by Aurora. They own a private company called Asterion, whom Hamish Sutherland is overseeing the building of a 4.3 million square foot grow facility in Australia.

CannTab Therapeutics, whom Hamish Sutherland is an advisor to, has a deal with FSD Pharma, to develop and manufacture products for medical application. 

Hamish Sutherland previously worked for Pfeizer for 25 years. I recommend reading up on him.

i made this connection, thanks to the post below.

Pieces of the puzzle are coming together. 

https://www.stockhouse.com/companies/bullboard/c.prev/preveceutical-medical-inc?postid=28697277
Bullboard Posts